AC Immune SA | CIK:0001651625 | 3

  • Filed: 3/20/2018
  • Entity registrant name: AC Immune SA (CIK: 0001651625)
  • Generator: EDGARfilings PROfile
  • SEC filing page: http://www.sec.gov/Archives/edgar/data/1651625/000095010318003508/0000950103-18-003508-index.htm
  • XBRL Instance: http://www.sec.gov/Archives/edgar/data/1651625/000095010318003508/aciu-20171231.xml
  • XBRL Cloud Viewer: Click to open XBRL Cloud Viewer
  • EDGAR Dashboard: https://edgardashboard.xbrlcloud.com/edgar-dashboard/?cik=0001651625
  • Open this page in separate window: Click
  • ifrs-full:DisclosureOfExpensesExplanatory

    14.
    Expenses by category

    Research and Development

      
    For the Years Ended
    December 31,
     
    in CHF thousands
     
    2017
      
    2016
      
    2015
     
    Operating expenses
      
    23,822
       
    18,767
       
    10,763
     
    Payroll expenses
      
    8,552
       
    6,450
       
    5,879
     
    Share-based compensation
      
    289
       
    557
       
    407
     
    Total research and development expenses
      
    32,663
       
    25,774
       
    17,049
     

    General and Administrative

      
    For the Years Ended
    December 31,
     
    in CHF thousands
     
    2017
      
    2016
      
    2015
     
    Operating expenses
      
    3,857
       
    3,168
       
    1,377
     
    Payroll expenses
      
    4,984
       
    3,969
       
    1,908
     
    Share-based compensation
      
    1,290
       
    759
       
    132
     
    Total general and administrative expenses
      
    10,131
       
    7,896
       
    3,417
     

    Financial Result, net

      
    For the Years Ended
    December 31,
     
    in CHF thousands
     
    2017
      
    2016
      
    2015
     
    Interest income/ (expense)
      
    184
       
    36
       
    55
     
    Foreign currency remeasurement gain/(loss), net
      
    (4,049
    )
      
    3,443
       
    1,598
     
    Other finance income/(expense)
      
    (7
    )
      
    (119
    )
      
    (7
    )
    Finance result, net
      
    (3,872
    )
      
    3,360
       
    1,646